BiotechTubeBiotechTube
Home/Xenon Pharmaceuticals/Ian Mortimer
IM

Ian Mortimer

President, Chief Executive Officer, and Director

Xenon Pharmaceuticals

Therapeutic Areas

NeurologyPsychiatry

Xenon Pharmaceuticals Pipeline

DrugIndicationPhase
XEN1101Major Depressive Disorder (MDD)Phase 3
XEN496 (NBI-921352)KCNQ2 Developmental and Epileptic EncephalopathyPhase 2/3
XEN053Undisclosed TargetPreclinical

Leadership Team at Xenon Pharmaceuticals

SA
Sherry Aulin
Chief Financial Officer
DC
Dr. Christopher Kenney
Chief Medical Officer
DS
Dr. Simon Pimstone
Co-Founder and Director
DM
Dr. Michael Hayden
Co-Founder, Chief Scientific Officer, and Director
DE
Dr. Elizabeth (Liz) Garofalo
Executive Vice President, Head of Clinical Development
DJ
Dr. Juan Carlos Lopez
Vice President, Discovery
DG
Dr. Gary Patou
Chief Development Officer
FJ
Felix J. Baker
Director
DA
Dr. Anthony (Tony) B. Evnin
Director
DD
Dr. David W. Crabb
Director
View full Xenon Pharmaceuticals profile